2024. 49. A SYSTEMATIC REVIEW OF HEALTH ECONOMIC EVALUATIONS OF PD-(L)1 INHIBITORS FOR FIRST-LINE TREATMENT AMONG PATIENTS WITH HIGH PD-L1 EXPRESSION NON-SMALL CELL LUNG CANCER. Vietnam Journal of Community Medicine. 65, Tiếng Anh (Dec. 2024). DOI:https://doi.org/10.52163/yhc.v65i13.1891.